Innate Pharma to Propose Corporate Governance Structure Change

MT Newswires Live

04/16

Innate Pharma (IPHA) said Wednesday it will seek approval from shareholders to change its governance from the current executive board/supervisory board structure to one with a CEO and board of directors.

The change, which aims to simplify and align the company's governance with international standards, will be proposed at the annual general meeting on May 22, Innate Pharma said.

If shareholders approve the change, current supervisory board chairwoman Irina Staatz-Granzer would be appointed chairwoman of the board, and current executive board chairman Jonathan Dickinson would be appointed CEO, the company said.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2527217156"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2527217156\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2527217156?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-04-16 21:07","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2527217156","market":"hk","top_or_hot":-1,"title":"Innate Pharma to Propose Corporate Governance Structure Change","media":"MT Newswires Live","content":"<html><body><p> Innate Pharma (IPHA) said Wednesday it will seek approval from shareholders to change its governance from the current executive board/supervisory board structure to one with a CEO and board of directors.</p><p>The change, which aims to simplify and align the company's governance with international standards, will be proposed at the annual general meeting on May 22, Innate Pharma said.</p><p>If shareholders approve the change, current supervisory board chairwoman Irina Staatz-Granzer would be appointed chairwoman of the board, and current executive board chairman Jonathan Dickinson would be appointed CEO, the company said.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Innate Pharma to Propose Corporate Governance Structure Change</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nInnate Pharma to Propose Corporate Governance Structure Change\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time smaller\">2025-04-16 21:07</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<html><body><p> Innate Pharma (IPHA) said Wednesday it will seek approval from shareholders to change its governance from the current executive board/supervisory board structure to one with a CEO and board of directors.</p><p>The change, which aims to simplify and align the company's governance with international standards, will be proposed at the annual general meeting on May 22, Innate Pharma said.</p><p>If shareholders approve the change, current supervisory board chairwoman Irina Staatz-Granzer would be appointed chairwoman of the board, and current executive board chairman Jonathan Dickinson would be appointed CEO, the company said.</p></body></html>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"IPHA","symbol_name":"Innate Pharma SA","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2527217156","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2527217156","pubTimestamp":1744808843,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Innate Pharma  said Wednesday it will seek approval from shareholders to change its governance from the current executive board/supervisory board structure to one with a CEO and board of directors.The change, which aims to simplify and align the company's governance with international standards, will be proposed at the annual general meeting on May 22, Innate Pharma said.If shareholders approve the change, current supervisory board chairwoman Irina Staatz-Granzer would be appointed chairwoman of the board, and current executive board chairman Jonathan Dickinson would be appointed CEO, the company said.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"IPHA":"Innate Pharma SA","IPHYF":"Innate Pharma","BK4139":"生物科技"},"translate_title":"Innate Pharma提议改变公司治理结构","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"IPHA":0.9,"IPHYF":1},"content_text":"Innate Pharma (IPHA) said Wednesday it will seek approval from shareholders to change its governance from the current executive board/supervisory board structure to one with a CEO and board of directors.The change, which aims to simplify and align the company's governance with international standards, will be proposed at the annual general meeting on May 22, Innate Pharma said.If shareholders approve the change, current supervisory board chairwoman Irina Staatz-Granzer would be appointed chairwoman of the board, and current executive board chairman Jonathan Dickinson would be appointed CEO, the company said.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}